Myoclonic jerks complicating treatment of acute promyelocytic leukemia: case report and literature review.

Rhee, John Y; Tremblay, Douglas; Chan, Amy M; Tallman, Martin S; Mascarenhas, John

Rhee, John Y; Tremblay, Douglas; Chan, Amy M; Tallman, Martin S; Mascarenhas, John.

Affiliation

Rhee JY; Department of Internal Medicine.
Tremblay D; Tisch Cancer Institute, and.
Chan AM; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY; and.
Tallman MS; Department of Hematology and Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Mascarenhas J; Tisch Cancer Institute, and.

Blood Adv ; 3(12): 1854-1857, 2019 06 25.

Article in En | MEDLINE | ID: mdl-31213431

Subject(s)

Antineoplastic Agents/toxicity; Arsenic Trioxide/toxicity; Drug Therapy, Combination/adverse effects; Leukemia, Promyelocytic, Acute/drug therapy; Myoclonus/chemically induced; Aged; Antineoplastic Agents/administration & dosage; Antineoplastic Agents/therapeutic use; Arsenic Poisoning/diagnosis; Arsenic Trioxide/administration & dosage; Arsenic Trioxide/therapeutic use; Drug Therapy, Combination/methods; Female; Humans; Idarubicin/administration & dosage; Idarubicin/therapeutic use; Leukemia, Promyelocytic, Acute/pathology; Remission Induction; Steroids/administration & dosage; Steroids/therapeutic use; Topoisomerase II Inhibitors/administration & dosage; Topoisomerase II Inhibitors/therapeutic use; Treatment Outcome; Tretinoin/administration & dosage; Tretinoin/analogs & derivatives; Tretinoin/therapeutic use; Withholding Treatment

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Promyelocytic, Acute / Drug Therapy, Combination / Arsenic Trioxide / Myoclonus / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Aged / Female / Humans Language: En Journal: Blood Adv Year: 2019 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google